Susan Molineaux is at it again: Weeks after biotech closes, she lands as CEO of cancer drug startup

The CEO scored big with the multiple myeloma drug Kyprolis, then fizzled with Calithera. Her new company is taking another approach to cancer.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news